HRP930753B1 - Acylaminbenzopyrrole derivatives - Google Patents

Acylaminbenzopyrrole derivatives

Info

Publication number
HRP930753B1
HRP930753B1 HR930753A HRP930753A HRP930753B1 HR P930753 B1 HRP930753 B1 HR P930753B1 HR 930753 A HR930753 A HR 930753A HR P930753 A HRP930753 A HR P930753A HR P930753 B1 HRP930753 B1 HR P930753B1
Authority
HR
Croatia
Prior art keywords
aryl
alkyl
alkylaryl
hydrogen
pct
Prior art date
Application number
HR930753A
Other languages
English (en)
Inventor
John E Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP930753A2 publication Critical patent/HRP930753A2/hr
Publication of HRP930753B1 publication Critical patent/HRP930753B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Soft Magnetic Materials (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Pyrrole Compounds (AREA)
HR930753A 1992-04-10 1993-04-02 Acylaminbenzopyrrole derivatives HRP930753B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86638292A 1992-04-10 1992-04-10

Publications (2)

Publication Number Publication Date
HRP930753A2 HRP930753A2 (en) 1994-10-31
HRP930753B1 true HRP930753B1 (en) 2000-10-31

Family

ID=25347493

Family Applications (1)

Application Number Title Priority Date Filing Date
HR930753A HRP930753B1 (en) 1992-04-10 1993-04-02 Acylaminbenzopyrrole derivatives

Country Status (31)

Country Link
US (1) US5498626A (cs)
EP (1) EP0635015B1 (cs)
JP (1) JP2544704B2 (cs)
KR (1) KR0179074B1 (cs)
CN (1) CN1038506C (cs)
AT (1) ATE148465T1 (cs)
AU (1) AU670270B2 (cs)
BR (1) BR9306221A (cs)
CA (1) CA2132706C (cs)
CZ (1) CZ282653B6 (cs)
DE (1) DE69307875T2 (cs)
DK (1) DK0635015T3 (cs)
EG (1) EG20466A (cs)
ES (1) ES2097496T3 (cs)
FI (2) FI111256B (cs)
GR (1) GR3022767T3 (cs)
HR (1) HRP930753B1 (cs)
HU (1) HUT64060A (cs)
IL (1) IL105309A0 (cs)
MX (1) MX9301996A (cs)
MY (1) MY115278A (cs)
NO (1) NO309860B1 (cs)
NZ (1) NZ251047A (cs)
PL (1) PL172232B1 (cs)
RU (1) RU2110516C1 (cs)
SK (1) SK278182B6 (cs)
TW (1) TW394769B (cs)
UA (1) UA34452C2 (cs)
WO (1) WO1993021180A1 (cs)
YU (1) YU48916B (cs)
ZA (1) ZA932536B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
UA27467C2 (uk) 1992-04-07 2000-09-15 Пфайзер Інк. ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
ATE170836T1 (de) * 1993-08-31 1998-09-15 Pfizer 5-arylindolderivate
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB9402011D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
FI971334A7 (fi) * 1994-08-03 1997-04-01 Asta Medica Ag Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, jo illa on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immu nomoduloiva vaikutus
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
AU3170099A (en) * 1998-04-16 1999-11-08 Yamanouchi Pharmaceutical Co., Ltd. Remedies for obesity
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
WO2004064747A2 (en) * 2003-01-22 2004-08-05 Gtx Inc. Treating androgen deficiency in female (adif)-associated conditions with sarms
NZ585671A (en) * 2007-12-07 2012-06-29 Pfizer Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
ATE156823T1 (de) * 1990-06-07 1997-08-15 Zeneca Ltd Therapeutische heterocyclische verbindungen
EP0592438B1 (en) * 1990-10-15 1997-08-27 Pfizer Inc. Indole derivatives
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
EP0619805B1 (en) * 1991-11-25 2000-03-15 Pfizer Inc. 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists

Also Published As

Publication number Publication date
YU48916B (sh) 2002-11-15
CZ282653B6 (cs) 1997-08-13
NO943803D0 (no) 1994-10-07
BR9306221A (pt) 1998-06-30
EG20466A (en) 1999-05-31
DK0635015T3 (da) 1997-03-17
CN1080288A (zh) 1994-01-05
TW394769B (en) 2000-06-21
FI20010214A7 (fi) 2001-02-05
HRP930753A2 (en) 1994-10-31
MY115278A (en) 2003-05-31
DE69307875T2 (de) 1997-05-22
CN1038506C (zh) 1998-05-27
US5498626A (en) 1996-03-12
JP2544704B2 (ja) 1996-10-16
KR950700903A (ko) 1995-02-20
ES2097496T3 (es) 1997-04-01
WO1993021180A1 (en) 1993-10-28
JPH07501831A (ja) 1995-02-23
ZA932536B (en) 1994-10-08
AU3782193A (en) 1993-11-18
RU2110516C1 (ru) 1998-05-10
AU670270B2 (en) 1996-07-11
EP0635015A1 (en) 1995-01-25
IL105309A0 (en) 1993-08-18
CA2132706C (en) 1998-08-04
CZ247794A3 (en) 1995-07-12
MX9301996A (es) 1994-03-31
SK278182B6 (en) 1996-03-06
GR3022767T3 (en) 1997-06-30
NZ251047A (en) 1996-09-25
FI20010214L (fi) 2001-02-05
HUT64060A (en) 1993-11-29
NO943803L (no) 1994-10-07
RU94045902A (ru) 1996-08-27
UA34452C2 (uk) 2001-03-15
FI931613A0 (fi) 1993-04-08
EP0635015B1 (en) 1997-01-29
KR0179074B1 (ko) 1999-03-20
FI111256B (fi) 2003-06-30
CA2132706A1 (en) 1993-10-28
ATE148465T1 (de) 1997-02-15
NO309860B1 (no) 2001-04-09
PL172232B1 (pl) 1997-08-29
YU25593A (sh) 1996-10-09
DE69307875D1 (de) 1997-03-13
FI931613L (fi) 1993-10-11
SK120794A3 (en) 1995-05-10
HU9301048D0 (en) 1993-06-28

Similar Documents

Publication Publication Date Title
GR3022767T3 (en) Acylaminoindole derivatives as 5-ht1 agonists.
MY108909A (en) Indole derivatives
TW229205B (cs)
MY111683A (en) Indole derivatives.
ATE170836T1 (de) 5-arylindolderivate
CA2117643A1 (en) Indole Derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040102

Year of fee payment: 12

PBON Lapse due to non-payment of renewal fee

Effective date: 20050403